- Ramadan fasting
- Heart rate
- Oxygen consumption
- Blood pressure
- Body composition
Objective: To study the effect of Ramadan fast (RF) on body composition, plasma constituents, hematology, and cardiorespiratory responses to constant submaximal exercise. Subjects and Methods: Sixteen sedentary healthy Kuwaiti adult males were included in the study. The subjects were tested under thermo-neutral conditions during a spring-like month of Ramadan and 2 months thereafter. They were tested during the week before RF (Pre1); the last 3 days of RF (End1); the week before a non-Ramadan month (Pre2), and the last 3 days of the non-Ramadan month (End2). The following measurements were made: body composition, cellular and biochemical constituents of blood, heart rate, ventilatory responses and blood pressure. Results: No significant changes were observed in body composition, cellular and biochemical constituents of blood. The heart rate and ventilatory responses to the moderately intense bouts of submaximal aerobic exercise (∼70% of VO2max) were significantly reduced (p < 0.04) while systolic blood pressure increased (p < 0.05) by the end of RF. Conclusions: Ramadan fasting had no adverse effect on the subjects when performing aerobic exercise at submaximal level. The mild changes in cardiorespiratory responses could be due to dehydration, abstention from consumption of substances with negative inotropy and circadian rhythms.
Copyright © 2002 S. Karger AG, Basel
- Husain R, Duncan MT, Cheah SH, Ch’ng SL: Effects of fasting in Ramadan on tropical Asiatic Moslems. Br J Nutr 1987;58:41.
- Jackson S, Pollock ML: Generalised equations for predicting body density in man. Br J Nutr 1978;40:497–504.
- Siri WE: Body composition from fluid spaces and density: Analysis of methods; in Brozek J, Henschel A (eds): Techniques for Measuring Body Compositions. Washington, National Academy of Science, 1961, p 233.
- Wilmore KM, McBride PJ, Wilmore JH: Comparison of bioelectric impedance and near-infrared interaction for body composition assessment in a population of self-perceived overweight adults. Int J Obes 1994;18:375–381.
- Bruce RL, Kusumi F, Hosmer D: Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 1973;85:545–562.
- Heyndrickx GR, Boettcher DH, Vanter SF: Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am J Physiol 1976;231:1579–1589.
- Farah AK: Glucagon and the circulation. Pharmacol Rev 1983;35:181–217.
- Laragh JH, Baer L, Brunner HR: Renin angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med 1972;52:633–652.
- Cahill GF, Herrera MG, Morgan AP, Soeldner JS: Hormone fuel interrelationships during fasting. J Clin Invest 1966;45:1751–1769.
- Wilcox CS, Puritz R, Lightm SL: Plasma volume regulation in patients with progressive autonomic failure during changes in salt intake or posture. J Lab Clin Med 1984;104:331–339.
- Ramadan J, Mousa M, Telahoun G: Effect of Ramadan fasting on physical performance, blood and body composition. Med Principles Pract 1994;95:204–212.
- Walker BR, Childs ME, Adams EM: Direct cardiac effects of vasopressin: Role of V1- and V2-vasopressinergic receptor. Am J Physiol 1988;255:H261–H265.
- Mustafa KY, Mahmoud NA, Gumaa KA, Gader AMA: The effects of fasting in Ramadan. Fluid and electrolyte balance. Br J Nutr 1978;40:83–89.
- Jasem R, Telahoun G, Al-Zaid NS, Barac-Nieto M: Responses to exercise, fluid and energy balance during Ramadan in sedentary and active males. Nutrition 1999;15:735–739.
Dr. Jasem Ramadan
Department of Physiology
Faculty of Medicine, Kuwait University
PO Box 24923, 13110 Safat (Kuwait)
Tel. +965 5319593, Fax +965 5338937, E-Mail firstname.lastname@example.org
Received: Received: March 11, 2002
Revised: July 30, 2002
Number of Figures : 3, Number of Tables : 4, Number of References : 14
Medical Principles and Practice
International Journal of the Kuwait University Health Sciences Centre A Publicationof the Academic Publications Council
Vol. 11, No. Suppl. 2, Year 2002 (Cover Date: Released November 2002)
Journal Editor: Farida Al Awadi, Kuwait
ISSN: 1011–7571 (print), 1423–0151 (Online)
For additional information: http://www.karger.com/journals/mpp
Open Access License / Drug Dosage / Disclaimer
Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license
), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.